nivolumab,ipilimumab
bms
['niche-2']
exceptionally effective: immunotherapy prior to colon cancer surgery. today at the esmo 2022 conference, has presented new, promising data of the niche-2-trial. learn more #esmo2022 
The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years. Our Dutch account is @hetAVL.